 Wei Perng
Concepts (433)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 38 | 2026 | 532 | 9.230 |
Why?
| | Prenatal Exposure Delayed Effects | 25 | 2026 | 652 | 6.680 |
Why?
| | Pediatric Obesity | 19 | 2026 | 638 | 4.720 |
Why?
| | Body Mass Index | 56 | 2026 | 2445 | 4.590 |
Why?
| | Metabolomics | 17 | 2026 | 732 | 3.450 |
Why?
| | Diabetes, Gestational | 12 | 2025 | 306 | 3.250 |
Why?
| | Environmental Pollutants | 11 | 2026 | 139 | 3.150 |
Why?
| | Diet | 22 | 2026 | 1277 | 3.110 |
Why?
| | Pregnancy | 76 | 2026 | 7202 | 2.990 |
Why?
| | Birth Weight | 20 | 2026 | 514 | 2.800 |
Why?
| | Cardiovascular Diseases | 14 | 2025 | 2187 | 2.760 |
Why?
| | Biomarkers | 36 | 2026 | 4295 | 2.640 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2023 | 265 | 2.380 |
Why?
| | Polycystic Ovary Syndrome | 7 | 2026 | 187 | 2.350 |
Why?
| | Child | 93 | 2026 | 22707 | 2.170 |
Why?
| | Weight Gain | 11 | 2023 | 561 | 2.160 |
Why?
| | DNA Methylation | 12 | 2024 | 674 | 2.010 |
Why?
| | Epigenesis, Genetic | 11 | 2025 | 679 | 1.960 |
Why?
| | Child Health | 7 | 2026 | 153 | 1.960 |
Why?
| | Obesity | 26 | 2025 | 3116 | 1.920 |
Why?
| | Insulin | 11 | 2026 | 2512 | 1.880 |
Why?
| | Female | 140 | 2026 | 78844 | 1.840 |
Why?
| | Leptin | 10 | 2024 | 248 | 1.820 |
Why?
| | Body Composition | 15 | 2023 | 693 | 1.820 |
Why?
| | Endocrine Disruptors | 4 | 2024 | 41 | 1.810 |
Why?
| | Environmental Exposure | 9 | 2026 | 578 | 1.770 |
Why?
| | Mothers | 10 | 2025 | 765 | 1.690 |
Why?
| | Child, Preschool | 53 | 2026 | 11853 | 1.570 |
Why?
| | Adolescent | 62 | 2026 | 22529 | 1.540 |
Why?
| | Metabolic Syndrome | 5 | 2021 | 360 | 1.520 |
Why?
| | Humans | 163 | 2026 | 145474 | 1.520 |
Why?
| | Prospective Studies | 38 | 2025 | 8057 | 1.520 |
Why?
| | Metabolome | 8 | 2026 | 388 | 1.490 |
Why?
| | Premature Birth | 9 | 2026 | 388 | 1.480 |
Why?
| | Inflammation | 8 | 2026 | 2878 | 1.440 |
Why?
| | Infant, Newborn | 38 | 2026 | 6447 | 1.430 |
Why?
| | Maternal Nutritional Physiological Phenomena | 7 | 2026 | 178 | 1.410 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2025 | 2588 | 1.410 |
Why?
| | Overnutrition | 3 | 2021 | 28 | 1.400 |
Why?
| | Hypertension, Pregnancy-Induced | 6 | 2025 | 69 | 1.390 |
Why?
| | Pregnancy Outcome | 7 | 2026 | 503 | 1.390 |
Why?
| | Body Weight | 7 | 2022 | 971 | 1.340 |
Why?
| | Waist Circumference | 11 | 2026 | 143 | 1.310 |
Why?
| | Insulin Resistance | 13 | 2026 | 1244 | 1.300 |
Why?
| | Overweight | 8 | 2024 | 614 | 1.300 |
Why?
| | Cohort Studies | 31 | 2026 | 6013 | 1.290 |
Why?
| | Stress, Psychological | 3 | 2023 | 1146 | 1.240 |
Why?
| | Fatty Liver | 4 | 2026 | 253 | 1.230 |
Why?
| | Fruit and Vegetable Juices | 2 | 2026 | 21 | 1.190 |
Why?
| | Placenta | 4 | 2026 | 786 | 1.170 |
Why?
| | Male | 82 | 2026 | 72842 | 1.150 |
Why?
| | Body Height | 5 | 2018 | 202 | 1.150 |
Why?
| | Blood Glucose | 13 | 2026 | 2341 | 1.150 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2013 | 32 | 1.140 |
Why?
| | Blood Pressure | 11 | 2025 | 1779 | 1.140 |
Why?
| | Fetal Blood | 6 | 2024 | 327 | 1.130 |
Why?
| | Risk Factors | 28 | 2025 | 10885 | 1.130 |
Why?
| | Health Status | 3 | 2024 | 832 | 1.110 |
Why?
| | C-Reactive Protein | 10 | 2026 | 422 | 1.100 |
Why?
| | Nutritional Status | 5 | 2026 | 353 | 1.100 |
Why?
| | Feeding Behavior | 4 | 2026 | 690 | 1.080 |
Why?
| | Fluorocarbons | 3 | 2025 | 120 | 1.030 |
Why?
| | Adult | 53 | 2026 | 40777 | 1.000 |
Why?
| | Child Development | 8 | 2026 | 483 | 0.980 |
Why?
| | Young Adult | 30 | 2026 | 14218 | 0.970 |
Why?
| | Lipase | 2 | 2026 | 75 | 0.950 |
Why?
| | Anti-Mullerian Hormone | 2 | 2025 | 61 | 0.950 |
Why?
| | Metabolic Diseases | 4 | 2021 | 114 | 0.940 |
Why?
| | Beverages | 1 | 2026 | 68 | 0.930 |
Why?
| | Adiponectin | 6 | 2025 | 241 | 0.910 |
Why?
| | Puberty | 4 | 2022 | 137 | 0.910 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2022 | 39 | 0.910 |
Why?
| | Mexico | 11 | 2023 | 233 | 0.900 |
Why?
| | Maternal Exposure | 5 | 2025 | 189 | 0.890 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2026 | 454 | 0.880 |
Why?
| | Phthalic Acids | 3 | 2024 | 42 | 0.880 |
Why?
| | Diabetic Neuropathies | 1 | 2025 | 100 | 0.840 |
Why?
| | Skinfold Thickness | 4 | 2018 | 43 | 0.820 |
Why?
| | Diabetic Angiopathies | 1 | 2025 | 264 | 0.790 |
Why?
| | Longitudinal Studies | 20 | 2026 | 2953 | 0.770 |
Why?
| | Psychological Tests | 1 | 2023 | 130 | 0.750 |
Why?
| | Lead | 2 | 2021 | 71 | 0.740 |
Why?
| | Genotype | 3 | 2026 | 1852 | 0.740 |
Why?
| | Liver | 4 | 2026 | 1896 | 0.730 |
Why?
| | Sexual Maturation | 2 | 2019 | 48 | 0.720 |
Why?
| | Self Report | 4 | 2023 | 870 | 0.710 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.700 |
Why?
| | Azocines | 1 | 2021 | 8 | 0.700 |
Why?
| | Diabetic Nephropathies | 1 | 2025 | 322 | 0.700 |
Why?
| | Hyaenidae | 1 | 2021 | 4 | 0.690 |
Why?
| | Infant | 29 | 2026 | 10077 | 0.690 |
Why?
| | Insulins | 1 | 2022 | 38 | 0.690 |
Why?
| | Cardiovascular System | 1 | 2023 | 138 | 0.680 |
Why?
| | Ecology | 1 | 2022 | 105 | 0.680 |
Why?
| | Massachusetts | 7 | 2025 | 180 | 0.670 |
Why?
| | Breast Feeding | 6 | 2026 | 446 | 0.670 |
Why?
| | Maternal Behavior | 1 | 2021 | 84 | 0.650 |
Why?
| | Biological Evolution | 2 | 2022 | 467 | 0.650 |
Why?
| | Lipid Metabolism | 1 | 2024 | 529 | 0.650 |
Why?
| | Hyperinsulinism | 1 | 2021 | 114 | 0.630 |
Why?
| | Triglycerides | 7 | 2023 | 520 | 0.630 |
Why?
| | Membrane Proteins | 2 | 2026 | 1164 | 0.620 |
Why?
| | Prediabetic State | 1 | 2023 | 249 | 0.610 |
Why?
| | Racism | 1 | 2022 | 146 | 0.610 |
Why?
| | Social Environment | 1 | 2021 | 252 | 0.600 |
Why?
| | Menopause | 5 | 2025 | 326 | 0.570 |
Why?
| | Islets of Langerhans | 2 | 2023 | 846 | 0.560 |
Why?
| | Socioeconomic Factors | 9 | 2026 | 1323 | 0.560 |
Why?
| | Epidemiology | 1 | 2018 | 32 | 0.560 |
Why?
| | Lipids | 3 | 2020 | 707 | 0.560 |
Why?
| | Hypertension | 4 | 2025 | 1273 | 0.550 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 72 | 0.540 |
Why?
| | Linear Models | 8 | 2024 | 845 | 0.540 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2018 | 13 | 0.530 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2018 | 47 | 0.530 |
Why?
| | Cholesterol | 4 | 2023 | 408 | 0.530 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 6 | 0.520 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2017 | 24 | 0.520 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 32 | 0.520 |
Why?
| | Adipose Tissue | 5 | 2020 | 645 | 0.520 |
Why?
| | Homeostasis | 2 | 2021 | 642 | 0.520 |
Why?
| | Adipokines | 3 | 2026 | 57 | 0.500 |
Why?
| | Sex Characteristics | 2 | 2020 | 782 | 0.500 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 143 | 0.490 |
Why?
| | Bone and Bones | 1 | 2019 | 317 | 0.490 |
Why?
| | Androgens | 1 | 2018 | 181 | 0.480 |
Why?
| | MicroRNAs | 1 | 2022 | 686 | 0.480 |
Why?
| | Gestational Age | 5 | 2026 | 987 | 0.470 |
Why?
| | Anthropometry | 6 | 2022 | 206 | 0.470 |
Why?
| | Follow-Up Studies | 9 | 2025 | 5423 | 0.460 |
Why?
| | Interleukin-6 | 5 | 2026 | 776 | 0.450 |
Why?
| | Signal Transduction | 3 | 2026 | 5216 | 0.450 |
Why?
| | Fetal Development | 1 | 2018 | 298 | 0.450 |
Why?
| | Micronutrients | 2 | 2013 | 102 | 0.440 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 317 | 0.440 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 1097 | 0.430 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.430 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 88 | 0.430 |
Why?
| | Maternal Welfare | 1 | 2014 | 22 | 0.430 |
Why?
| | Colombia | 6 | 2018 | 42 | 0.420 |
Why?
| | Carbon Isotopes | 2 | 2025 | 143 | 0.420 |
Why?
| | Choline | 2 | 2025 | 137 | 0.420 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 26 | 0.410 |
Why?
| | Alu Elements | 1 | 2013 | 28 | 0.400 |
Why?
| | Residence Characteristics | 3 | 2026 | 375 | 0.400 |
Why?
| | Air Pollution | 3 | 2025 | 314 | 0.390 |
Why?
| | Abdominal Fat | 3 | 2023 | 51 | 0.390 |
Why?
| | Homocysteine | 1 | 2013 | 152 | 0.390 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.380 |
Why?
| | Age Factors | 6 | 2025 | 3342 | 0.370 |
Why?
| | Intra-Abdominal Fat | 3 | 2023 | 101 | 0.370 |
Why?
| | Sex Factors | 5 | 2026 | 2105 | 0.370 |
Why?
| | Air Pollutants | 3 | 2025 | 405 | 0.370 |
Why?
| | Growth Disorders | 1 | 2013 | 89 | 0.370 |
Why?
| | Fatty Acids | 2 | 2020 | 457 | 0.370 |
Why?
| | Endotoxins | 2 | 2023 | 217 | 0.360 |
Why?
| | Poliomyelitis | 1 | 2012 | 35 | 0.360 |
Why?
| | Infertility | 2 | 2022 | 61 | 0.350 |
Why?
| | American Heart Association | 2 | 2024 | 358 | 0.350 |
Why?
| | Health Behavior | 4 | 2024 | 789 | 0.350 |
Why?
| | Diseases in Twins | 1 | 2012 | 116 | 0.340 |
Why?
| | Postpartum Period | 3 | 2020 | 373 | 0.340 |
Why?
| | Food Hypersensitivity | 2 | 2024 | 164 | 0.340 |
Why?
| | Milk, Human | 2 | 2026 | 174 | 0.330 |
Why?
| | Twins | 1 | 2012 | 152 | 0.330 |
Why?
| | Nutrition Policy | 2 | 2026 | 57 | 0.330 |
Why?
| | Boston | 4 | 2025 | 93 | 0.320 |
Why?
| | Causality | 2 | 2021 | 126 | 0.310 |
Why?
| | Atherosclerosis | 1 | 2013 | 409 | 0.300 |
Why?
| | Logistic Models | 4 | 2025 | 2134 | 0.300 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5904 | 0.290 |
Why?
| | Age of Onset | 2 | 2022 | 555 | 0.290 |
Why?
| | C-Peptide | 2 | 2021 | 190 | 0.290 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2023 | 3922 | 0.290 |
Why?
| | Phospholipases A2, Calcium-Independent | 2 | 2026 | 18 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2026 | 1217 | 0.280 |
Why?
| | Exercise | 4 | 2025 | 2198 | 0.280 |
Why?
| | Acyltransferases | 2 | 2026 | 78 | 0.270 |
Why?
| | Principal Component Analysis | 3 | 2019 | 193 | 0.270 |
Why?
| | United States | 10 | 2026 | 16098 | 0.270 |
Why?
| | Middle Aged | 14 | 2025 | 36215 | 0.270 |
Why?
| | Child Care | 2 | 2024 | 36 | 0.260 |
Why?
| | Phenols | 2 | 2026 | 106 | 0.260 |
Why?
| | Infant, Small for Gestational Age | 3 | 2026 | 118 | 0.240 |
Why?
| | Alkanesulfonic Acids | 2 | 2025 | 35 | 0.230 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1547 | 0.230 |
Why?
| | Regression Analysis | 3 | 2018 | 1001 | 0.230 |
Why?
| | Nonprescription Drugs | 1 | 2026 | 69 | 0.230 |
Why?
| | Obesity, Abdominal | 1 | 2026 | 47 | 0.230 |
Why?
| | Thinness | 1 | 2026 | 100 | 0.230 |
Why?
| | Dietary Sugars | 1 | 2025 | 21 | 0.220 |
Why?
| | Odds Ratio | 3 | 2023 | 1082 | 0.220 |
Why?
| | Colorado | 5 | 2024 | 4553 | 0.220 |
Why?
| | Population Dynamics | 1 | 2026 | 142 | 0.220 |
Why?
| | Genome-Wide Association Study | 2 | 2023 | 1407 | 0.220 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2026 | 128 | 0.220 |
Why?
| | Incidence | 3 | 2023 | 2923 | 0.220 |
Why?
| | Absorptiometry, Photon | 3 | 2026 | 277 | 0.220 |
Why?
| | Asthma | 4 | 2023 | 1797 | 0.210 |
Why?
| | Child Behavior | 2 | 2024 | 236 | 0.210 |
Why?
| | Parabens | 1 | 2024 | 11 | 0.210 |
Why?
| | Hyperglycemia | 2 | 2018 | 379 | 0.210 |
Why?
| | Genetic Association Studies | 2 | 2019 | 369 | 0.210 |
Why?
| | Hyperandrogenism | 1 | 2025 | 25 | 0.210 |
Why?
| | Prevalence | 3 | 2025 | 2865 | 0.200 |
Why?
| | Vulnerable Populations | 1 | 2025 | 176 | 0.200 |
Why?
| | Acetaminophen | 1 | 2026 | 267 | 0.200 |
Why?
| | Birth Order | 1 | 2023 | 14 | 0.200 |
Why?
| | Pregnancy Complications | 3 | 2020 | 602 | 0.190 |
Why?
| | Diabetic Retinopathy | 1 | 2025 | 209 | 0.190 |
Why?
| | Parturition | 2 | 2022 | 68 | 0.190 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2158 | 0.190 |
Why?
| | Immunoglobulin E | 1 | 2024 | 315 | 0.190 |
Why?
| | Phenotype | 2 | 2022 | 3155 | 0.190 |
Why?
| | Vegetables | 2 | 2020 | 161 | 0.180 |
Why?
| | Cannabidiol | 1 | 2024 | 142 | 0.180 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 47 | 0.180 |
Why?
| | Amino Acids | 1 | 2026 | 519 | 0.180 |
Why?
| | Adolescent Behavior | 2 | 2024 | 494 | 0.180 |
Why?
| | Michigan | 2 | 2020 | 134 | 0.180 |
Why?
| | Dronabinol | 1 | 2024 | 249 | 0.170 |
Why?
| | Plethysmography | 2 | 2022 | 104 | 0.170 |
Why?
| | Toxoplasmosis, Animal | 1 | 2021 | 8 | 0.170 |
Why?
| | Carbohydrates | 1 | 2021 | 66 | 0.170 |
Why?
| | Cholesterol, LDL | 2 | 2022 | 360 | 0.170 |
Why?
| | Educational Status | 1 | 2023 | 466 | 0.170 |
Why?
| | Hand Strength | 1 | 2022 | 144 | 0.170 |
Why?
| | Lysine | 1 | 2024 | 305 | 0.170 |
Why?
| | Antibodies, Protozoan | 1 | 2021 | 41 | 0.170 |
Why?
| | Glucose Tolerance Test | 2 | 2025 | 360 | 0.170 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2023 | 531 | 0.170 |
Why?
| | Toxoplasma | 1 | 2021 | 49 | 0.170 |
Why?
| | Latin America | 1 | 2021 | 96 | 0.170 |
Why?
| | Dermatitis, Atopic | 1 | 2024 | 322 | 0.170 |
Why?
| | Health Status Disparities | 1 | 2024 | 321 | 0.160 |
Why?
| | Sarcopenia | 1 | 2022 | 91 | 0.160 |
Why?
| | Cats | 1 | 2021 | 231 | 0.160 |
Why?
| | Protective Factors | 1 | 2021 | 99 | 0.160 |
Why?
| | Testosterone | 1 | 2025 | 416 | 0.160 |
Why?
| | Selection, Genetic | 1 | 2022 | 261 | 0.160 |
Why?
| | Scotland | 1 | 2019 | 30 | 0.150 |
Why?
| | Pre-Eclampsia | 1 | 2022 | 206 | 0.150 |
Why?
| | Problem Behavior | 1 | 2021 | 101 | 0.150 |
Why?
| | Precision Medicine | 1 | 2023 | 459 | 0.150 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 368 | 0.140 |
Why?
| | Health Surveys | 1 | 2021 | 518 | 0.140 |
Why?
| | Acetylcarnitine | 1 | 2018 | 6 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2022 | 558 | 0.140 |
Why?
| | Aminoisobutyric Acids | 1 | 2018 | 9 | 0.140 |
Why?
| | Hydroxyproline | 1 | 2018 | 18 | 0.140 |
Why?
| | Fasting | 1 | 2020 | 279 | 0.140 |
Why?
| | Infant, Premature | 2 | 2025 | 619 | 0.140 |
Why?
| | Ornithine | 1 | 2018 | 27 | 0.140 |
Why?
| | Asparagine | 1 | 2018 | 35 | 0.140 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 858 | 0.140 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 227 | 0.140 |
Why?
| | Phospholipids | 1 | 2019 | 214 | 0.140 |
Why?
| | Carnitine | 1 | 2018 | 91 | 0.140 |
Why?
| | Feces | 1 | 2021 | 495 | 0.130 |
Why?
| | Mental Health | 1 | 2024 | 793 | 0.130 |
Why?
| | Comorbidity | 1 | 2023 | 1661 | 0.130 |
Why?
| | Immunoglobulin G | 1 | 2022 | 892 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1891 | 0.130 |
Why?
| | Smoking | 1 | 2025 | 1472 | 0.130 |
Why?
| | Economic Development | 1 | 2017 | 2 | 0.130 |
Why?
| | History, 21st Century | 1 | 2018 | 222 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 3 | 2026 | 3904 | 0.130 |
Why?
| | Mass Spectrometry | 2 | 2018 | 730 | 0.130 |
Why?
| | Pediatrics | 3 | 2024 | 1121 | 0.130 |
Why?
| | Energy Intake | 3 | 2025 | 512 | 0.130 |
Why?
| | Sleep | 1 | 2024 | 888 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2021 | 531 | 0.130 |
Why?
| | Snacks | 2 | 2015 | 22 | 0.130 |
Why?
| | Energy Metabolism | 2 | 2021 | 935 | 0.120 |
Why?
| | Risk Assessment | 2 | 2024 | 3747 | 0.120 |
Why?
| | Health Promotion | 1 | 2023 | 775 | 0.120 |
Why?
| | Dietary Fats | 2 | 2018 | 308 | 0.120 |
Why?
| | Mexican Americans | 1 | 2017 | 119 | 0.120 |
Why?
| | Prehypertension | 1 | 2015 | 27 | 0.110 |
Why?
| | Trans Fatty Acids | 1 | 2015 | 5 | 0.110 |
Why?
| | Glucose | 1 | 2021 | 1048 | 0.110 |
Why?
| | Risk | 1 | 2018 | 919 | 0.110 |
Why?
| | Developing Countries | 1 | 2017 | 316 | 0.110 |
Why?
| | Pregnancy Trimesters | 1 | 2014 | 20 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1118 | 0.110 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2015 | 106 | 0.110 |
Why?
| | Cognition | 1 | 2023 | 1266 | 0.110 |
Why?
| | Body Weights and Measures | 1 | 2014 | 37 | 0.110 |
Why?
| | Prognosis | 3 | 2021 | 4316 | 0.110 |
Why?
| | Urban Population | 1 | 2017 | 493 | 0.100 |
Why?
| | Aging | 2 | 2023 | 1969 | 0.100 |
Why?
| | New York City | 1 | 2013 | 84 | 0.100 |
Why?
| | Los Angeles | 1 | 2013 | 73 | 0.100 |
Why?
| | Adaptation, Physiological | 1 | 2018 | 560 | 0.100 |
Why?
| | Epigenomics | 2 | 2024 | 114 | 0.100 |
Why?
| | Mitochondria | 1 | 2020 | 992 | 0.100 |
Why?
| | Carbonated Beverages | 1 | 2013 | 16 | 0.100 |
Why?
| | Dietary Sucrose | 1 | 2013 | 50 | 0.100 |
Why?
| | Iron Overload | 1 | 2013 | 19 | 0.100 |
Why?
| | Food, Fortified | 1 | 2013 | 44 | 0.100 |
Why?
| | Vitamin A | 1 | 2012 | 60 | 0.090 |
Why?
| | Ferritins | 1 | 2012 | 70 | 0.090 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 62 | 0.090 |
Why?
| | Animals | 6 | 2021 | 38030 | 0.090 |
Why?
| | Sweden | 1 | 2012 | 115 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 128 | 0.090 |
Why?
| | CpG Islands | 2 | 2024 | 163 | 0.090 |
Why?
| | Vitamin B 12 | 1 | 2012 | 135 | 0.090 |
Why?
| | Bronchial Neoplasms | 1 | 2011 | 15 | 0.080 |
Why?
| | Folic Acid | 1 | 2012 | 198 | 0.080 |
Why?
| | Aged | 2 | 2025 | 26153 | 0.080 |
Why?
| | Particulate Matter | 2 | 2025 | 326 | 0.080 |
Why?
| | Immunization Programs | 1 | 2012 | 193 | 0.080 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2013 | 268 | 0.080 |
Why?
| | Iron | 1 | 2012 | 357 | 0.080 |
Why?
| | Diet Surveys | 2 | 2021 | 90 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2013 | 293 | 0.070 |
Why?
| | Zinc | 1 | 2012 | 306 | 0.070 |
Why?
| | Colonic Neoplasms | 1 | 2011 | 257 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2023 | 3623 | 0.070 |
Why?
| | SRS-A | 1 | 1987 | 17 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2864 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2930 | 0.070 |
Why?
| | Medicaid | 1 | 2012 | 467 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 1987 | 47 | 0.070 |
Why?
| | Prednisolone | 1 | 1987 | 67 | 0.060 |
Why?
| | Muscles | 2 | 2022 | 330 | 0.060 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6066 | 0.060 |
Why?
| | Patient Acceptance of Health Care | 1 | 2013 | 881 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2022 | 17291 | 0.060 |
Why?
| | Alberta | 1 | 2025 | 25 | 0.060 |
Why?
| | Bangladesh | 1 | 2026 | 63 | 0.060 |
Why?
| | Nitrogen Dioxide | 1 | 2025 | 45 | 0.060 |
Why?
| | Procollagen | 1 | 2025 | 24 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3413 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 1 | 2026 | 174 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 2026 | 156 | 0.050 |
Why?
| | Ozone | 1 | 2025 | 115 | 0.050 |
Why?
| | Mass Screening | 1 | 2013 | 1360 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1419 | 0.050 |
Why?
| | Collagen Type I | 1 | 2025 | 143 | 0.050 |
Why?
| | Canada | 1 | 2025 | 431 | 0.050 |
Why?
| | Hot Flashes | 1 | 2025 | 91 | 0.050 |
Why?
| | Esters | 1 | 2024 | 71 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2011 | 925 | 0.050 |
Why?
| | Academic Success | 1 | 2023 | 30 | 0.050 |
Why?
| | Parity | 1 | 2023 | 111 | 0.050 |
Why?
| | Organophosphates | 1 | 2024 | 179 | 0.050 |
Why?
| | Accelerometry | 1 | 2023 | 118 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 40 | 0.050 |
Why?
| | Oxylipins | 1 | 2023 | 47 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 614 | 0.050 |
Why?
| | Life Style | 2 | 2016 | 485 | 0.040 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2022 | 15 | 0.040 |
Why?
| | Starch | 1 | 2022 | 22 | 0.040 |
Why?
| | Longevity | 1 | 2023 | 178 | 0.040 |
Why?
| | Food | 1 | 2022 | 150 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2025 | 693 | 0.040 |
Why?
| | Allergens | 1 | 2024 | 386 | 0.040 |
Why?
| | Bone Density | 1 | 2025 | 487 | 0.040 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2022 | 154 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1327 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8333 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2022 | 145 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 296 | 0.040 |
Why?
| | Parents | 2 | 2024 | 1403 | 0.040 |
Why?
| | Cardiology | 1 | 2024 | 362 | 0.040 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 217 | 0.040 |
Why?
| | Dietary Exposure | 1 | 2020 | 8 | 0.040 |
Why?
| | Louisiana | 1 | 2020 | 31 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 151 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 335 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 110 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 420 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2020 | 90 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2021 | 180 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 740 | 0.040 |
Why?
| | Eating | 1 | 2022 | 387 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 287 | 0.040 |
Why?
| | Genitalia | 1 | 2018 | 33 | 0.030 |
Why?
| | Edible Grain | 1 | 2018 | 47 | 0.030 |
Why?
| | Public Health | 1 | 2023 | 572 | 0.030 |
Why?
| | Menarche | 1 | 2018 | 53 | 0.030 |
Why?
| | Quality of Life | 2 | 2025 | 3204 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2021 | 519 | 0.030 |
Why?
| | Cities | 1 | 2018 | 138 | 0.030 |
Why?
| | Meat | 1 | 2018 | 64 | 0.030 |
Why?
| | Testis | 1 | 2018 | 162 | 0.030 |
Why?
| | Social Class | 1 | 2019 | 264 | 0.030 |
Why?
| | Breast | 1 | 2018 | 156 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2018 | 147 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2018 | 135 | 0.030 |
Why?
| | Autoimmunity | 1 | 2023 | 933 | 0.030 |
Why?
| | Lactation | 1 | 2018 | 193 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 450 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1734 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2016 | 83 | 0.030 |
Why?
| | Linoleic Acid | 1 | 2015 | 44 | 0.030 |
Why?
| | Oleic Acid | 1 | 2015 | 40 | 0.030 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2015 | 55 | 0.030 |
Why?
| | Vitamin D | 1 | 2018 | 403 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 1137 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 858 | 0.030 |
Why?
| | Notophthalmus viridescens | 1 | 1993 | 1 | 0.030 |
Why?
| | Radio | 1 | 2013 | 2 | 0.030 |
Why?
| | Salamandridae | 1 | 1993 | 33 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2018 | 583 | 0.020 |
Why?
| | Tanzania | 1 | 2013 | 72 | 0.020 |
Why?
| | Consumer Health Information | 1 | 2013 | 49 | 0.020 |
Why?
| | Depression | 1 | 2022 | 1546 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2378 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1993 | 531 | 0.020 |
Why?
| | Information Systems | 1 | 2012 | 56 | 0.020 |
Why?
| | Acclimatization | 1 | 1993 | 170 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1747 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 140 | 0.020 |
Why?
| | Models, Biological | 1 | 2018 | 1764 | 0.020 |
Why?
| | Models, Statistical | 1 | 2014 | 671 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2011 | 305 | 0.020 |
Why?
| | Digestive System Surgical Procedures | 1 | 2011 | 112 | 0.020 |
Why?
| | Chemoradiotherapy | 1 | 2011 | 239 | 0.020 |
Why?
| | Data Collection | 1 | 2012 | 640 | 0.020 |
Why?
| | Rural Population | 1 | 2013 | 659 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 688 | 0.020 |
Why?
| | Airway Resistance | 1 | 1987 | 38 | 0.020 |
Why?
| | Vaccines | 1 | 2012 | 388 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 11772 | 0.010 |
Why?
| | Phosphocreatine | 1 | 1993 | 44 | 0.010 |
Why?
| | Phosphates | 1 | 1993 | 177 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 546 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1993 | 500 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1993 | 627 | 0.010 |
Why?
| | Temperature | 1 | 1993 | 633 | 0.010 |
Why?
|
|
Perng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|